Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARCH: Autonomic and Renal Contributions to Hypertension With ADT
NCT05700903Phase 4Terminated
- Sponsor
- University of Colorado Denver
- Start
- Sep 2023
- Primary completion
- Jul 2025
- Countries
- 1
01
Overview
Phase 4, randomised trial in prostate cancer (PCa) (3 arms), sponsored by University of Colorado Denver. Primary endpoints: Change in Cardiovagal Baroreflex Sensitivity at 9 weeks, Change in Blood Pressure Reactivity to the Cold Pressor Test at 9 weeks and 5 more. Started Sep 2023; status: terminated.
02
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT05700903.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05700903.